Literature DB >> 10406456

Iron-mediated cardiovascular injury.

L D Horwitz1, E A Rosenthal.   

Abstract

Iron is an essential element for normal cellular function and general health. However, iron may play a pathologic role in certain cardiac conditions including reperfusion injury, hemochromatosis, beta-thalassemia and coronary atherosclerosis. It also may play a role in injury due to anthracycline cardiotoxicity. Removal of iron via phlebotomy for hemochromatosis and chelation therapy for beta-thalassemia are proven treatments. Cell culture, and isolated organ and animal studies suggest that depleting iron stores may prevent reperfusion injury, restenosis and even atherogenesis. This article will review mechanisms by which iron overload states and normal iron stores contribute to cardiovascular pathophysiology and the accumulating evidence that iron chelation may prevent restenosis and atherogenesis.

Entities:  

Mesh:

Year:  1999        PMID: 10406456     DOI: 10.1177/1358836X9900400207

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  22 in total

Review 1.  The exochelins of pathogenic mycobacteria: unique, highly potent, lipid- and water-soluble hexadentate iron chelators with multiple potential therapeutic uses.

Authors:  Lawrence D Horwitz; Marcus A Horwitz
Journal:  Antioxid Redox Signal       Date:  2014-06-20       Impact factor: 8.401

Review 2.  In situ imaging of metals in cells and tissues.

Authors:  Reagan McRae; Pritha Bagchi; S Sumalekshmy; Christoph J Fahrni
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

3.  Improvements in cardiac function detected using echocardiography in patients with hereditary haemochromatosis.

Authors:  Danielle Byrne; John Patrick Walsh; Caroline Daly; Susan McKiernan; Suzanne Norris; Ross T Murphy; Gerard King
Journal:  Ir J Med Sci       Date:  2019-05-20       Impact factor: 1.568

4.  Fe²⁺ block and permeation of CaV3.1 (α1G) T-type calcium channels: candidate mechanism for non-transferrin-mediated Fe²⁺ influx.

Authors:  Kyle V Lopin; I Patrick Gray; Carlos A Obejero-Paz; Frank Thévenod; Stephen W Jones
Journal:  Mol Pharmacol       Date:  2012-09-12       Impact factor: 4.436

Review 5.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

6.  Hydrogen peroxide enhances iron-induced injury in isolated heart and ventricular cardiomyocyte in rats.

Authors:  Ying Ying Chen; Kwok Pin Ho; Qiang Xia; Zhong Ming Qian
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

7.  Bone Microthrombus Promotes Bone Loss in Iron Accumulation Rats.

Authors:  Hai-Feng Hang; Long-Jia Dong; Xin-Bing Tang; Ai-Fei Wang; Fan Yang; Hui Zhang; You-Jia Xu
Journal:  Curr Med Sci       Date:  2020-10-29

Review 8.  Metal Nanomaterial Toxicity Variations Within the Vascular System.

Authors:  Alaeddin B Abukabda; Phoebe A Stapleton; Timothy R Nurkiewicz
Journal:  Curr Environ Health Rep       Date:  2016-12

Review 9.  Non transferrin bound iron: nature, manifestations and analytical approaches for estimation.

Authors:  Meghna Patel; D V S S Ramavataram
Journal:  Indian J Clin Biochem       Date:  2012-08-31

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.